Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al
About the GEMINI-1 Clinical Trial The GEMINI-1 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m 2 ) or overweight (BMI 24 kg/m 2 ) and at least one weight-related comorbidity without diabetes
New 2025 clinical research shows that GLP-1 medications like Ozempic (semaglutide) may significantly reduce alcohol cravings and heavy drinking
This may include: BMI 30, or 27 with related conditions Documented attempts at calorie reduction Exercise or physical activity history Behavioral or lifestyle counseling These requirements do not need to be perfectbut they do need to be documented
Label the vial with the fill volume, resulting concentration and reconstitution date
Testosterone and estradiol formulations come in milligrams per milliliter: mg per mL
